Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy

Journal article
(Editorial)


Publication Details

Author(s): Wanner C, Gerrnain DP, Hilz MJ, Spada M, Falissard B, Elliott PM
Journal: Molecular Genetics and Metabolism
Publication year: 2019
Volume: 126
Journal issue: 3
Pages range: 210-211
ISSN: 1096-7192


FAU Authors / FAU Editors

Hilz, Max-Josef Prof. Dr. med.
Professur für Neurologie


External institutions with authors

École Polytechnique - Université Paris-Saclay
Julius-Maximilians-Universität Würzburg
University College London (UCL)
University of Paris 5 - René Descartes / Université Paris V René Descartes
University of Turin / Università degli Studi di Torino (UNITO)


How to cite

APA:
Wanner, C., Gerrnain, D.P., Hilz, M.-J., Spada, M., Falissard, B., & Elliott, P.M. (2019). Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy. Molecular Genetics and Metabolism, 126(3), 210-211. https://dx.doi.org/10.1016/j.ymgme.2018.04.004

MLA:
Wanner, Christoph, et al. "Therapeutic goals in Fabry disease: Recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy." Molecular Genetics and Metabolism 126.3 (2019): 210-211.

BibTeX: 

Last updated on 2019-23-05 at 10:08